Homegrown and Groundbreaking Molecular Bypass Research
Researchers in Perth, WA, have developed a new kind of medicine that’s offering hope for people with neuromuscular conditions.
Different to genetic engineering, the technique works like a genetic patch, which jumps over a disease-causing part of the message as the DNA is being copied.
The research is being carried out by Prof Steve Wilton and his team at the University of Western Australia.
The ABC’s science program Catalyst has highlighted the work of the researchers at The University of Western Australia who have developed a new treatment offering hope for people with serious illness including neuromuscular conditions.
Both Steve Wilton and Professor Sue Fletcher, of the Molecular Genetic Therapies Group at UWA’s Centre for Neuromuscular and Neurological Disorders, are part of an international research team that last year revealed a breakthrough that may lead to a new therapeutic approach for the treatment of Duchenne muscular dystrophy (DMD), an incurable muscle-wasting disease.
Professor Wilton said the technique had enormous implications for a variety of conditions including cancer, asthma, Alzheimer’s and diabetes.
Click here to view the story on Catalyst.